Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL-Reference-Cited by-同舟云学术

Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL

Published:2021-03-16 Issue: Volume: Page:
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Nix Matthew A.^ORCID,Mandal Kamal,Geng Huimin,Paranjape Neha,Lin Yu-Hsiu T.,Rivera Jose M.,Marcoulis Makeba,White Kristie L.,Whitman Jeffrey D.^ORCID,Bapat Sagar P.^ORCID,Parker Kevin R.^ORCID,Ramirez Jonathan,Deucher Anne,Phojanokong Paul,Steri Veronica^ORCID,Fattahi Faranak,Hann Byron C.,Satpathy Ansuman T.^ORCID,Manglik Aashish,Stieglitz Elliot^ORCID,Wiita Arun P.^ORCID

Funder

HHS | NIH | National Cancer Institute

HHS | NIH | National Institute of General Medical Sciences

Burroughs Wellcome Fund

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR T-cell therapy in cancer: Integrating nursing perspectives for enhanced patient care;Asia-Pacific Journal of Oncology Nursing;2024-10

2. T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting;Molecular Therapy;2024-09

3. Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma;Blood Neoplasia;2024-09

4. Progress in the Utilization of Nanobody CAR-T Cell in Cancer Immunotherapy;Journal of Biomedical Nanotechnology;2024-08-01

5. Alternative target recognition elements for chimeric antigen receptor (CAR) T cells: beyond standard antibody fragments;Cytotherapy;2024-07